Oncology is one of the most complex and competitive therapeutic areas, with an ever-expanding pipeline of treatments, rapid scientific progress, and increasing pressure on access and positioning. At APLUSA, we provide clarity across this complexity by combining real-world patient data, syndicated trackers, and advanced behavioral insights.

Our expertise covers both solid tumors and hematologic malignancies, helping pharma and biotech teams to size opportunities, refine value stories, and track market dynamics throughout the product lifecycle.

Some of the areas we’ve explored

• Bladder Cancer (Urothelial Carcinoma, m-UC)
• Biosimilars vs. Branded Therapies
• Melanoma
• Mesothelioma
• mRCC (Metastatic Renal Cell Carcinoma)
• NSCLC (Non-Small Cell Lung Cancer)
• Ovarian Cancer
• Prostate Cancer